Bersani, F. S., Girardi, N., Sanna, L., Mazzarini, L., Santucci, C., Kotzalidis, G. D., & Girardi, P. (2013). Neurocase, 19(5), 451-457. This case report examines the effect of Brainsway® Deep TM...Read More
This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Journal: Journal of Affective Disorders 235:20-26 (2018)
Authors: M.L Myczkowski, A Fernandes, M Moreno, L Valiengo, B Lafer, R.A Moreno, F Padberg, W Gattaz, A.R Brunon
Bipolar depression (BD) is a highly prevalent condition associated with marked cognitive deficitsthat persist even in the euthymic phase of the illness. Pharmacological treatments for BD might further aggravate cognitive impairment, highlighting the need of developing interventions that present cognitive safety.
In this study, the investigators evaluated the cognitive effects of H1-coil (deep) transcranial magnetic stimulation(TMS) in patients with treatment-resistant bipolar depression.
Fourty-three patients were randomized to receive 20 sessions of active (55 trains, 18 Hz, 120% resting motor threshold intensity) or sham rTMS within a double-blind, sham-controlledtrial. A battery of 20 neuropsychological assessments, grouped in 6 domains (attention and processing speed, working memory and executive function, inhibitory control, language, immediate verbal memory, and long-term verbal memory) was performed at baseline and after 4 and 8 weeks of trial onset. Depressive symptoms were assessed with the 17-item Hamilton Rating Scale for Depression.
Cognitive improvement was shown for all cognitive domains. It occurred regardless of interventiongroup and depression improvement. For the language domain, greater improvement was observed in the sham group over time. No correlations between depression (at baseline or during treatment) and cognitive improvement were found.
The results of this exploratory study provide evidence on the cognitive safety of H1-coil TMS for BD patients. Putative pro-cognitive effects of rTMS in BD were not observed and thus should be further investigated.